Journal of Pharmacobio-Dynamics, volume 8, issue 11, pages 917-923
Alpha-adrenolytic properties of apogalanthamine and azapetine analogs.
Yukio Ishida
,
Yuji Sasaki
,
Yukio Kimura
,
Kozo Watanabe
Publication type: Journal Article
Publication date: 2011-11-28
Journal:
Journal of Pharmacobio-Dynamics
SJR: —
CiteScore: —
Impact factor: —
ISSN: 0386846X, 18811353
PubMed ID:
2869118
Pharmacology
Abstract
Selectivities were examined between alpha 1 and alpha 2-adrenolytic activities of two apogalanthamine analogs (dibenzazocine derivatives), 6-methyl-5,6,7,8-tetrahydrodibenz[c,e]-azocine (DA-VIII-Me) and its N-allyl analog (DA-VIII-allyl), and two dibenzazepine derivatives, azapetine (DA-VII-allyl) and its N-methyl analog (DA-VII-Me). The alpha-adrenolytic activities were evaluated as inhibitory effects against the response to norepinephrine of isolated vas deferens and anococcygeus muscle of rats. The pA2 values for DA-VIII-Me, DA-VIII-allyl, DA-VII-Me and azapetine on the isolated rat vas deferens were 7.32, 7.76. 6.61 and 7.78 respectively, which were similar to those on the anococcygeus muscle. The alpha 2-adrenolytic activities of these compounds against the twitch-inhibitory response to clonidine in transmurally stimulated rat vas deferens and guinea-pig ileum were less potent than those against the above alpha 1-adrenoceptors. In addition, their inhibitory activities on the aggregation of human platelets induced by norepinephrine were weaker than those of phentolamine and yohimbine. These results indicate that the apogalanthamine and azapetine analogs tested are more selective in blocking alpha 1-adrenoceptors than alpha 2-adrenoceptors.
Found
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.